Education
About Us
Working with TipRanks
Follow Us
Kymera Therapeutics, Inc. (KYMR)
:KYMR
KYMR Analyst Ratings
Strong Buy
15 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KYMR Stock 12 Month Forecast
Average Price Target
$60.50
▲(30.28%Upside)
| Highest Price Target$79.00 | Average Price Target$60.50 | Lowest Price Target$51.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$50
Hold
7.67%
Upside
Reiterated
06/07/25
Stifel Nicolaus
$43.13→$68
Buy
46.43%
Upside
Reiterated
06/09/25
Leerink Partners
$60
Buy
29.20%
Upside
Reiterated
06/03/25
B.Riley Financial
$38→$60
Buy
29.20%
Upside
Upgraded
06/03/25
H.C. Wainwright
$54
Buy
16.28%
Upside
Reiterated
06/03/25
Morgan Stanley
$49→$79
Buy
70.11%
Upside
Upgraded
06/03/25
UBS
$70
Buy
50.73%
Upside
Reiterated
06/03/25
Guggenheim
$52→$60
Buy
29.20%
Upside
Reiterated
06/02/25
Wells Fargo
$57
Buy
22.74%
Upside
Assigned
06/02/25
Citi
$52→$60
Buy
29.20%
Upside
Reiterated
06/02/25
J.P. Morgan
$57→$64
Buy
37.81%
Upside
Reiterated
06/02/25
BTIG
$55
Buy
18.43%
Upside
Reiterated
06/02/25
Truist Financial
$53
Buy
14.13%
Upside
Reiterated
06/02/25
Bank of America Securities
$44→$51
Buy
9.82%
Upside
Upgraded
06/02/25
Oppenheimer
$56
Buy
20.59%
Upside
Reiterated
05/12/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$50
Hold
7.67%
Upside
Reiterated
06/07/25
Stifel Nicolaus
$43.13→$68
Buy
46.43%
Upside
Reiterated
06/09/25
Leerink Partners
$60
Buy
29.20%
Upside
Reiterated
06/03/25
B.Riley Financial
$38→$60
Buy
29.20%
Upside
Upgraded
06/03/25
H.C. Wainwright
$54
Buy
16.28%
Upside
Reiterated
06/03/25
Morgan Stanley
$49→$79
Buy
70.11%
Upside
Upgraded
06/03/25
UBS
$70
Buy
50.73%
Upside
Reiterated
06/03/25
Guggenheim
$52→$60
Buy
29.20%
Upside
Reiterated
06/02/25
Wells Fargo
$57
Buy
22.74%
Upside
Assigned
06/02/25
Citi
$52→$60
Buy
29.20%
Upside
Reiterated
06/02/25
J.P. Morgan
$57→$64
Buy
37.81%
Upside
Reiterated
06/02/25
BTIG
$55
Buy
18.43%
Upside
Reiterated
06/02/25
Truist Financial
$53
Buy
14.13%
Upside
Reiterated
06/02/25
Bank of America Securities
$44→$51
Buy
9.82%
Upside
Upgraded
06/02/25
Oppenheimer
$56
Buy
20.59%
Upside
Reiterated
05/12/25
Best Analysts Covering Kymera Therapeutics
1 Month
xxx
Success Rate
7/11 ratings generated profit
Average Return
+11.34%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.64% of your transactions generating a profit, with an average return of +11.34% per trade.
3 Months
xxx
Success Rate
8/12 ratings generated profit
Average Return
+24.97%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +24.97% per trade.
1 Year
Success Rate
8/9 ratings generated profit
Average Return
+26.70%
reiterated a buy rating 18 days ago
Copying Faisal Khurshid's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +26.70% per trade.
2 Years
xxx
Success Rate
12/13 ratings generated profit
Average Return
+54.57%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 92.31% of your transactions generating a profit, with an average return of +54.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KYMR Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
8
11
10
11
11
Buy
9
7
5
4
15
Hold
4
4
3
5
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
22
18
20
30
Each month's total comprises the sum of three months' worth of ratings.
KYMR Financial Forecast
KYMR Stock Forecast FAQ
What is KYMR’s average 12-month price target, according to analysts?
Based on analyst ratings, Kymera Therapeutics, Inc.’s 12-month average price target is 60.50.
What is KYMR’s upside potential, based on the analysts’ average price target?
Kymera Therapeutics, Inc. has 30.28% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KYMR a Buy, Sell or Hold?
Kymera Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 15 buy ratings, 0 hold ratings and 0 sell ratings.
What is Kymera Therapeutics, Inc.’s price target?
The average price target for Kymera Therapeutics, Inc. is 60.50. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $79.00 ,the lowest forecast is $51.00. The average price target represents 30.28% Increase from the current price of $46.44.
The highest analyst price target is $79.00 ,the lowest forecast is $51.00. The average price target represents 30.28% Increase from the current price of $46.44.
What do analysts say about Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of KYMR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.